FY2024 EPS Estimates for REGENXBIO Decreased by Analyst
REGENXBIO Inc. (NASDAQ:RGNX – Free Report) – Leerink Partnrs lowered their FY2024 earnings per share (EPS) estimates for shares of REGENXBIO in a research note issued on Wednesday, February 19th. Leerink Partnrs analyst M. Foroohar now expects that the biotechnology company will post earnings per share of ($4.93) for the year, down from their previous […]
